Windlas Biotech Ltd (WINDLAS) — Announcement | 1 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Windlas Biotech announces virtual investor meeting schedule for September 7, 2026
💡 Investor Takeaway
Shareholders should note the company is proactively engaging investors through scheduled virtual meetings without revealing new price-sensitive information.

Windlas Biotech announced its schedule for virtual investor and analyst meetings on September 7, 2026, including one-on-one sessions with ICICI Direct, Bajaj Broking, and Haitong Securities, and a group investor meeting, all conducted via virtual platform starting at 2:00 PM IST, with no UPSI to be discussed and potential schedule changes possible.

📄 View Original Announcement (PDF)

About Windlas Biotech Ltd (WINDLAS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹2,079.31 Cr P/E: 31.9 ROE: 11.4% ROCE: 15.0% Div Yield: 0.63%

View full WINDLAS stock details →

📡 Get AI alerts when WINDLAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track WINDLAS — Free

📊 More WINDLAS filings

See all WINDLAS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when WINDLAS files new disclosures

Track WINDLAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track WINDLAS — Free

Free account · 2 AI queries/day